PMID- 11151395 OWN - NLM STAT- MEDLINE DCOM- 20010201 LR - 20220331 IS - 1170-7690 (Print) IS - 1170-7690 (Linking) VI - 18 IP - 5 DP - 2000 Nov TI - The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? PG - 419-23 AB - It is generally believed that small differences in health-related quality of life (HR-QOL) may be statistically significant yet clinically unimportant. The concept of the minimal clinically meaningful difference (MCID) has been proposed to refer to the smallest difference in a HR-QOL score that is considered to be worthwhile or clinically important. However, there is danger in oversimplification in asking the question: what is the MCID on this HR-QOL instrument? We argue that the attempt to define a single MCID is problematic for a number of reasons and recommend caution in the search for the MCID holy grail. Specifically, absolute thresholds are suspect because they ignore the cost or resources required to produce a change in HR-QOL. In addition, there are several practical problems in estimating the MCID, including: (i) the estimated magnitude varies depending on the distributional index and the external standard or anchor; (ii) the amount of change might depend on the direction of change; and (iii) the meaning of change depends on where you start (baseline value). FAU - Hays, R D AU - Hays RD AD - Division of General Internal Medicine and Health Services Research, UCLA Department of Medicine, 911 Broxton Plaza, Room 110, Box 951736, Los Angeles, CA 90095-1736, USA. hays@rand.org FAU - Woolley, J M AU - Woolley JM LA - eng PT - Journal Article PL - New Zealand TA - Pharmacoeconomics JT - PharmacoEconomics JID - 9212404 MH - Clinical Trials as Topic/methods MH - *Health Status Indicators MH - Humans MH - *Quality of Life MH - Research Design EDAT- 2001/01/11 11:00 MHDA- 2001/02/28 10:01 CRDT- 2001/01/11 11:00 PHST- 2001/01/11 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2001/01/11 11:00 [entrez] AID - 10.2165/00019053-200018050-00001 [doi] PST - ppublish SO - Pharmacoeconomics. 2000 Nov;18(5):419-23. doi: 10.2165/00019053-200018050-00001.